New AI-powered assistant offers designers step-by-step guidance and recommendations during design process Onshape Government delivers cloud-native CAD and PDM to aerospace and defense companies with ITAR and EAR compliance requirements BOSTON, April 15, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced two new offerings from its cloud-native Onshape® computer-aided design (CAD) and product data management (PDM) platform: Onshape AI Advisor, an intelligent, generative AI-powered assistant that enables ...

Core Viewpoint - PTC is set to release its fiscal 2025 second quarter results on April 30, 2025, with a live webcast and conference call scheduled for the same day at 5 PM Eastern Time [1][2]. Company Overview - PTC is a global software company focused on enabling industrial and manufacturing companies to digitally transform their design, manufacturing, and service processes [4]. - The company is headquartered in Boston, Massachusetts, employs over 7,000 people, and supports more than 30,000 customers worldwide [4].

Core Insights - PTC has announced the acquisition of IncQuery Group, which specializes in application lifecycle management (ALM) and systems engineering consultancy services for global manufacturers and product companies [1][2] - The acquisition aims to enhance PTC's capabilities in ALM, systems engineering, and product lifecycle management (PLM), thereby improving support for customers in these areas [1][2] Company Overview - PTC is a global software company headquartered in Boston, Massachusetts, employing over 7,000 people and serving more than 30,000 customers worldwide [3] - The company focuses on enabling manufacturers and product companies to digitally transform their design, manufacturing, and service processes for physical products [3] Strategic Importance - The acquisition is positioned as a strategic move to accelerate PTC's ALM and PLM portfolio integrations, addressing customer needs for faster and higher-quality product development while meeting regulatory and sustainability requirements [2] - Both PTC and IncQuery Group share a commitment to transforming digital engineering and product development processes, which is expected to enhance PTC's engineering and product development portfolio [2]

Core Insights - PTC Inc. has launched Codebeamer 3.0, an advanced Application Lifecycle Management (ALM) solution designed to enhance product development, sustainability, quality, and regulatory compliance [1][4]. Product Features - Codebeamer 3.0 introduces a modern branching method and scaled working sets to improve collaboration among engineering teams, enabling faster development by reusing product requirements and test cases [2]. - The new version includes a Sustainability Template to support eco-friendly product development, reducing reliance on physical prototypes and promoting sustainable design practices [3]. - For industries with stringent regulatory requirements, Codebeamer 3.0 provides full traceability across products, aiding in quality assurance and compliance [3]. Strategic Collaborations - PTC has formed strategic collaborations, including a partnership with Microsoft and Volkswagen Group to develop Codebeamer Copilot, an AI-powered tool aimed at streamlining software development processes for physical products [4]. - In September 2024, PTC signed a strategic collaboration agreement with Amazon Web Services to enhance its Onshape solution, focusing on improving features and advancing AI efforts [7]. Financial Outlook - PTC has narrowed its sales outlook for 2025 to a range of $2,430 million to $2,530 million, down from the previous projection of $2,505 million to $2,605 million, due to forex volatility and a challenging sales environment [8]. Market Performance - PTC currently holds a Zacks Rank of 3 (Hold), with its shares declining by 15.4% over the past year, compared to a 4% decline in the Zacks Computer-Software industry [9].

WARREN, N.J., March 28, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the European Commission (EC) has adopted the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) to not renew the authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy. While this action effectively removes the drug's conditional marketing authorization in the European Economic Area, the EC indicat ...

Industry-leading ALM solution delivers enhanced speed and scalability with variant management Modern branching method and scaled working sets enable customers to accelerate development of products and ensure compliance Sustainability Template offers eco-friendly design best practices and reduces physical prototypes through reuse Provides end-to-end traceability and process support for product compliance in regulated industries BOSTON, March 27, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the rel ...

PTC Inc (PTC) is set to exhibit its latest innovation, Windchill AI, at Hannover Messe 2025, strengthening its position in AI-powered product lifecycle management (PLM). Windchill AI is an AI-powered assistant that leverages the vast amount of product data stored in Windchill, PTC’s flagship PLM solution. This advanced AI tool enables engineers and designers to access information faster, streamline decision-making and improve product development efficiency. In addition to Windchill AI, PTC will exhibit its ...

PTC to preview Windchill AI and Document Vault AI agent PTC to demonstrate agentic AI across the product digital thread with Windchill AI, Codebeamer AI, and ServiceMax AI PTC demonstrations available in Hall 17, Stand D40 from March 31 – April 4, 2025 BOSTON, March 25, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) will preview its Windchill® AI product lifecycle management (PLM) assistant, a generative AI-powered PLM offering, at Hannover Messe 2025. Windchill AI leverages all product data stored in Windchill to ...

BOSTON, March 13, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it has appointed Trac Pham to its Board of Directors, effective March 17, 2025.Pham is the former Chief Financial Officer of Synopsys, a recognized leader in electronic design automation and semiconductor development. During his tenure as CFO, Pham led Synopsys through two significant transformations that helped scale the company from $2.0B to $5.1B in revenue while expanding operating margins. He is currently on the Board of Dire ...

Group 1 - PTC Therapeutics is facing declining revenues and profitability but is preparing for a turnaround [1] - The company has potential asymmetric upside due to several regulatory catalysts expected in 2025, including the FDA review of vatiquinone for Friedreich's ataxia and sepiapterin [1]